Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...

Sabre is regaining ground after a tough year, President and CEO Kurt Ekert told Skift after the company’s third-quarter ...

Vietnamese fashion brand Coolmate has raised new Series C funding to accelerate growth, expand its offerings, and strengthen ...

President William Ruto has pledged to ensure that the Orange Democratic Movement (ODM) remains a central part of Kenya’s political future, saying the party will either form the next government or be ...

The stock of niche financial software company Vertex ( VERX 4.13%) didn't get a very good start to the trading week at all.

KING OF PRUSSIA, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results ...

'No child should go through this' | Warner Robins toddler battles rare form of cancer Chevron payments make up nearly 24% of Richmond general fund, California city reveals accidentally Fact check: 11 ...

Aston Villa captain John McGinn says his side cannot allow the shock Europa League loss to Dutch minnows Go Ahead Eagles to derail their Premier League form. Emiliano Buendia missed a late spot-kick ...

Community driven content discussing all aspects of software development from DevOps to design patterns. If you want to get certified as a Generative AI Leader by Google, you need to do more than just ...

In the tenth instalment of Metro’s In The Mixer, we’re looking at where Liverpool have been going wrong this season, and how Arne Slot can fix the problems they are having. Sign up to receive this, ...

These questions come from my Udemy training and the certificationexams.pro website, resources that have helped many students pass the DP-100 certification. These are not DP-100 exam dumps or ...

Data presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions 2025- -Phase 1 ...